Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $29.35. The company's market cap stands at 167.52B, with a P/E ratio of 42.03 and a dividend yield of 5.85%.
On 2026-11-07, Pfizer(PFE) stock moved within a range of $28.54 to $29.43. With shares now at $29.35, the stock is trading +2.8% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 48.32M, compared to an average daily volume of 41.34M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
PFE News
Eli Lilly (LLY -0.79%) is much loved on Wall Street because of its highly successful GLP-1 weight-loss business. Novo Nordisk (NVO +0.03%) is much less apprecia...
Pfizer (NYSE:PFE) plans to invest US$650 million in a new manufacturing technology center at its Connecticut R&D campus. The facility is intended to produce cl...
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S ((TSE:PFE)) has held its Q3 earnings call. Read on for the main highlights of the call....
Analyst ratings
60%
of 30 ratingsMore PFE News
Investing Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027? A blockbuster blood thinner is about to lose $1.5 billion to $2 billion in sales,...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s Phase 3 study, officially titled “A PHASE 3, RANDOMIZED, DOUBLE-...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer’s Phase 3 study, titled “A Phase 3, Randomized, Double-Blind, Placebo-Controlled S...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer’s recruiting Phase 1 study, officially titled “PHASE 1, SINGLE DOSE, OPEN-LABEL, R...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer’s NCT07839871, titled “A Phase 3 Study to Evaluate the Safety, Tolerability, and I...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s study, officially titled “Describing Prescription Patterns in an...
Pfizer (NYSE:PFE) CEO used a recent investor appearance to set out a plan for a renewed push into obesity treatments. Management highlighted the historic comme...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.